Skip to main content

Table 4 Predictors of hypertension control among patients who linked to hypertension care following population-level screening and had at least one subsequent follow-up visit (n = 1587)

From: Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study

  Unadjusted OR (95% CI) for HTN control p-value Adjusted OR (95% CI) for HTN control p value
Sex   0.08   0.03
 Female 1.0   1.0  
 Male 0.87 (0.75, 1.01)   0.88 (0.78, 0.99)  
Age   0.02   0.01
  < 50 years 1.0   1.0  
  > = 50 years 0.82 (0.69, 0.97)   0.83 (0.73, 0.95)  
Diabetes present   0.9   0.8
 No 1.0   1.0  
 Yes 1.02 (0.80, 1.31)   0.98 (0.80, 1.19)  
Time since first clinic visit (months) 1.03 (1.03, 1.03) < 0.001 1.02 (1.01, 1.02) < 0.001
Hypertension Stage at previous visit
 0 1.0 < 0.001 1.0 < 0.001
 1 0.51 (0.46, 0.57)   0.63 (0.55, 0.71)  
 2 0.26 (0.23, 0.29)   0.33 (0.28, 0.38)  
Anti-hypertensive Medication prescribed at previous visit   0.02   0.15
 Yes 1.26 (1.07, 1.49)   1.09 (0.94, 1.26)  
 No 1.0   1.0  
HIV Status   0.04   0.11
 Known-infected 1.35 (1.02, 1.78)   1.28 (0.95, 1.71)  
 Known-uninfected 1.0   1.0  
Scheduled visit interval   0.03   0.05
 Per HTN treatment guidelines* 1.0   1.0  
 More frequently than guidelines* 0.81 (0.75, 0.87)   0.89 (0.79, 0.99)  
Clinic   < 0.001   < 0.001
 Bugamba 0.65 (0.50, 0.85)   0.67 (0.54, 0.85)  
 Kameke 4.37 (3.19, 6.00)   3.79 (2.86, 5.04)  
 Kamuge 1.39 (1.10, 1.75)   1.64 (1.34, 2.00)  
 Kazo 1.64 (1.18, 2.29)   1.60 (1.20, 2.11)  
 Merikit 1.81 (1.37, 2.31)   1.74 (1.38, 2.19)  
 Mitooma 1.0   1.0  
 Muyembe 1.91 (1.45, 2.52)   1.89 (1.50, 2.37)  
 Nankoma 1.91 (1.39, 2.64)   1.89 (1.50, 2.37)  
 Rubaare 1.07 (0.78, 1.48)   1.10 (0.85, 1.44)  
 Ruhoko 1.26 (0.91, 1.73)   1.16 (0.91, 1.49)  
  1. *Guidelines are to schedule follow-up visit 4 weeks later for patients with uncontrolled hypertension (stage 1 or stage 2) and every 3 months for patients with controlled hypertension (stage 0) at previous visit. More frequently than guidelines is a scheduled follow-up visit < 84 days when blood pressure is controlled (SBP < 140 and DBP < 90)